Effect of intravitreal injections due to neovascular age-related macular degeneration on retinal nerve fiber layer thickness and minimum rim width: a cross sectional study
Authors:
Open Access
- 23 April 2024
- journal article
- research article
- Published by Springer Nature in BMC Ophthalmology
- Vol. 24 (1) , 1-9
Abstract
Purpose: The present study tested the hypothesis that repeated anti-VEGF injections are associated with reduced retinal nerve fiber layer (RNFL) and minimum rim width (MRW) of the optic nerve head. Patients and methods: Sixty-six patients with a history of intravitreal injections due to neovascular age-related macular degeneration were included. RNFL and MRW were measured using optical coherence tomography (Spectralis OCT, Heidelberg Engineering, Heidelberg, Germany). Results: Mean global RNFL was 90.62 μm and both RNFL as well as MRW significantly decreased with advanced age (p = 0.005 and p = 0.019, respectively). Correlating for the number of injections, no significant impact on RNFL was found globally (p = 0.642) or in any of the sectors. In contrast, however, global MRW was significantly reduced with increasing numbers of intravitreal injections (p = 0.012). The same holds true when adjusted for the confounding factor age (RNFL p = 0.566 and MRW p = 0.023). Conclusion: Our study shows that repeated intravitreal injections due to choroidal neovascularization seem to have a deleterious effect on MRW but not on RNFL. This suggests that MRW is a more sensitive marker than RNFL for evaluating the effect of frequent intravitreal injections on the optic nerve head since it seems to be the first structure affected.Keywords
This publication has 33 references indexed in Scilit:
- Dose-Response Relationship between Intravitreal Injections and Retinal Nerve Fiber Layer Thinning in Age-Related Macular DegenerationOphthalmology Retina, 2021
- Acute and chronic optic nerve head biomechanics and intraocular pressure changes in patients receiving multiple intravitreal injections of anti-VEGFGraefe's Archive for Clinical and Experimental Ophthalmology, 2019
- Long-term effect of intravitreal ranibizumab therapy on retinal nerve fiber layer in eyes with exudative age-related macular degenerationGraefe's Archive for Clinical and Experimental Ophthalmology, 2019
- Individualized Stabilization Criteria–Driven Ranibizumab versus Laser in Branch Retinal Vein OcclusionOphthalmology, 2016
- Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein OcclusionOphthalmology, 2016
- Peripapillary RNFL thickness in nonexudative versus chronically treated exudative age-related macular degenerationCanadian Journal of Ophthalmology, 2015
- Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up. (BERVOLT study: Bevacizumab for RVO long-term follow-up)Graefe's Archive for Clinical and Experimental Ophthalmology, 2015
- The long-term effect of intravitreal ranibizumab on retinal nerve fiber layer thickness in exudative age-related macular degenerationInternational Ophthalmology, 2014
- Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular DegenerationOphthalmology, 2012
- Ranibizumab for Diabetic Macular EdemaOphthalmology, 2012